One of the last hurdles on the $69 billion deal was met Monday when New York regulators signed after CVS agreed to several requirements, including that acquisition costs will not be passed onto consumers or to affiliated insurers covering New Yorkers.

from Kaiser Health News https://ift.tt/2FJe1Aa

Related Posts:

0 comments:

Post a Comment

Popular Posts